Graf Akcie ALKS (Alkermes plc). Diskuze k akciím ALKS. Aktuální informace ALKS.

Základní informace o společnosti Alkermes plc (Akcie ALKS)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 5.02B
Hodnota podniku (EV) 4.65B
Tržby 1.1B
EBITDA -14.66
Zisk -62.83
Růst v tržbách Q/Q 22.70 %
Růst v tržbách Y/Y -5.30 %
P/E (Cena vůči ziskům) N/A
Forward P/E 0.29
EV/Sales 4.22
EV/EBITDA N/A
EV/EBIT N/A
PEG 2.31
Price/Sales 4.56
P/FCF 55.82
Price/Book 4.70
Účetní hodnota na akcii 6.73
Hotovost na akcii 4.01
FCF vůči ceně 1.79 %
Počet zaměstnanců 2,245
Tržba na zaměstnance 490.046k
Profit margin -10.67 %
Operating margin -4.85 %
Gross margin 82.83 %
EBIT margin -3.85 %
EBITDA margin -1.33 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 400.00 %
EPS - Očekávaný růst příští rok -80.77 %
Return on assets -3.29 %
Return on equity -5.84 %
ROIC -4.68 %
ROCE -2.73 %
Dluhy/Equity 0.83
Čistý dluh/EBITDA 43.28
Current ratio 2.71
Quick Ratio 2.35
Volatilita 2.46
Beta 0.74
RSI 56.90
Cílová cena analytiků 19
Známka akcie (dle analytiků) 3.00
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 161.332M
Procento shortovaných akcií 9.15 %
Short ratio 5.02 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 1991
Země Ireland

Finanční výsledky akcie ALKS

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$1,038.756$1,170.947$1,094.274$903.374$745.694$628.335
Cost Of Goods Sold$178.316$180.385$176.42$154.748$132.122$138.989
Gross Profit$860.44$990.562$917.854$748.626$613.572$489.346
Research And Development Expenses$394.588$512.833$425.406$412.889$387.148$344.404
SG&A Expenses$538.827$599.449$526.408$421.578$374.13$311.558
Other Operating Income Or Expenses------
Operating Expenses$1,151.183$1,346.426$1,193.402$1,051.274$954.359$852.636
Operating Income$-112.427$-175.479$-99.128$-147.9$-208.665$-224.301
Total Non-Operating Income/Expense$15.89$-21.577$-27.839$4.626$-5.722$0.296
Pre-Tax Income$-96.537$-197.056$-126.967$-143.274$-214.387$-224.005
Income Taxes$14.324$-0.436$12.344$14.671$-5.943$3.158
Income After Taxes$-110.861$-196.62$-139.311$-157.945$-208.444$-227.163
Other Income------
Income From Continuous Operations$-110.861$-196.62$-139.311$-157.945$-208.444$-227.163
Income From Discontinued Operations------
Net Income$-110.861$-196.62$-139.311$-157.945$-208.444$-227.163
EBITDA$-30.573$-95.066$4.532$-49.377$-114.409$-138.705
EBIT$-112.427$-175.479$-99.128$-147.9$-208.665$-224.301
Basic Shares Outstanding159157155153151149
Shares Outstanding159157155153151149
Basic EPS$-0.70$-1.25$-0.90$-1.03$-1.38$-1.52
EPS - Earnings Per Share$-0.70$-1.25$-0.90$-1.03$-1.38$-1.52
# 2020 2019 2018 2017 2016 2015
Current Ratio2.5352.45962.89382.77843.72973.1962
Long-term Debt / Capital0.20320.20170.1910.1880.18830.1778
Debt/Equity Ratio0.25770.25530.23850.2340.23450.2663
Gross Margin82.833784.59583.877982.8782.28277.8798
Operating Margin-10.8233-14.9861-9.0588-16.372-27.9827-35.6977
EBIT Margin-10.8233-14.9861-9.0588-16.372-27.9827-35.6977
EBITDA Margin-2.9432-8.11870.4142-5.4658-15.3426-22.075
Pre-Tax Profit Margin-9.2935-16.8288-11.6029-15.8599-28.75-35.6506
Net Profit Margin-10.6725-16.7915-12.7309-17.4839-27.953-36.1532
Asset Turnover0.53280.64860.59960.50260.43190.3386
Inventory Turnover Ratio1.41821.77191.9561.65912.09723.6185
Receiveable Turnover3.77534.55473.74473.86733.90214.0411
Days Sales In Receivables96.680380.137297.472394.379993.5490.3224
ROE - Return On Equity-10.3902-18.1143-11.8939-13.1314-17.2342-17.2843
Return On Tangible Equity-12.8472-23.3536-15.6986-18.4998-26.1083-26.9721
ROA - Return On Assets-5.686-10.8906-7.6335-8.7883-12.0738-12.2411
ROI - Return On Investment-8.2788-14.4602-9.6226-10.663-13.9882-14.2112
Book Value Per Share6.70386.87957.51997.817.93468.7211
Operating Cash Flow Per Share0.0628-0.18120.5150.5463-0.1507-0.3472
Free Cash Flow Per Share0.3743-0.31010.40390.4999-0.0868-0.7717

Porovnání s konkurencí: Akcie ALKS

Společnost P/E PEG Růst v tržbách (roční) Růst v EPS Return on equity P/B Profit margin
ALKS N/A 2.31 -5.30 % -80.77 % -5.84 % 4.70 -10.67 %
Akcie ACOR N/A N/A -5.03 % 13.04 % -55.69 % 0.22 -65.11 %
Akcie BMY N/A 14.08 27.31 % 19.02 % -12.51 % 3.43 -21.20 %
Akcie AZN 41.82 1.02 14.90 % 40.43 % 26.02 % 10.19 11.81 %
Akcie JNJ 23.93 1.67 10.79 % 7.27 % 27.01 % 6.67 17.82 %
Akcie PFE 17.66 1.97 4.96 % 50.00 % 19.81 % 3.72 22.95 %
Akcie TEVA N/A 0.79 -0.96 % 12.07 % -39.21 % 1.08 -23.95 %
Akcie ZGNX N/A N/A 801.95 % -11.11 % -70.65 % 2.47 -1,534.73 %

Nedávné obchody insiderů: Akcie ALKS

Jméno Obchod Cena Objem
Craig C. Hopkinson
EVP R, D, and Chief Medical Officer
Option
16 Feb 2021
$19.79 $66,791
Blair Curtis Jackson
EVP and Chief Operating Officer
Option
16 Feb 2021
$19.79 $91,529
Michael J Landine
SVP, Corp Dev., Alkermes, and Inc.
Option
16 Feb 2021
$19.79 $126,161
Richard F Pops
Director, CEO, and Alkermes plc
Option
16 Feb 2021
$19.79 $531,856
Iain Michael Brown
SVP and Chief Financial Officer
Option
20 Feb 2021
$19.58 $183,837
David Joseph Gaffin
SVP, CLO, Alkermes, and Inc.
Option
20 Feb 2021
$19.58 $272,377
Craig C. Hopkinson
EVP R, D, and Chief Medical Officer
Option
20 Feb 2021
$19.58 $332,273
Blair Curtis Jackson
EVP and Chief Operating Officer
Option
20 Feb 2021
$19.58 $183,837
Michael J Landine
SVP, Corp Dev., Alkermes, and Inc.
Option
20 Feb 2021
$19.58 $218,865
Christian Todd Nichols
SVP and Chief Commercial Officer
Option
20 Feb 2021
$19.58 $74,874
Richard F Pops
Director, CEO, and Alkermes plc
Option
21 Feb 2021
$19.58 $634,392
Craig C. Hopkinson
EVP R, D, and Chief Medical Officer
Option
16 Feb 2021
$19.79 $66,791
Blair Curtis Jackson
EVP and Chief Operating Officer
Option
16 Feb 2021
$19.79 $91,529
Michael J Landine
SVP, Corp Dev., Alkermes, and Inc.
Option
16 Feb 2021
$19.79 $126,161
Richard F Pops
Director, CEO, and Alkermes plc
Option
16 Feb 2021
$19.79 $531,856
Iain Michael Brown
SVP and Chief Financial Officer
Option
20 Feb 2021
$19.58 $183,837
David Joseph Gaffin
SVP, CLO, Alkermes, and Inc.
Option
20 Feb 2021
$19.58 $272,377
Craig C. Hopkinson
EVP R, D, and Chief Medical Officer
Option
20 Feb 2021
$19.58 $332,273
Blair Curtis Jackson
EVP and Chief Operating Officer
Option
20 Feb 2021
$19.58 $183,837
Michael J Landine
SVP, Corp Dev., Alkermes, and Inc.
Option
20 Feb 2021
$19.58 $218,865
Christian Todd Nichols
SVP and Chief Commercial Officer
Option
20 Feb 2021
$19.58 $74,874
Richard F Pops
Director, CEO, and Alkermes plc
Option
21 Feb 2021
$19.58 $634,392

Diskuze k akciím ALKS